News
Selvita to Present New Data from its Oncology Programs at the Upcoming SITC 2018
Selvita , a clinical stage drug discovery and development company focused on innovative medicines for oncology patients, will publish the most recent data from...
Drug Research
Celerion Expands NASH Biomarkers Services With the Implementation of FibroScan
Celerion, a leader in early clinical research, is pleased to announce the implementation of FibroScan® to complement a suite of soluble biomarkers Celerion has...
Press Releases
Aptar Pharma Co-Organizes the Third Edition of RDD Asia in Kerala, India
Aptar Pharma is pleased to announce the co-organization and its diamond sponsorship of the third Respiratory Drug Delivery (RDD®) Asia scientific conference, which will...
Press Releases
Plasticell receives EU funding as part of €3.7 million consortium to advance neurodegenerative disease research
Plasticell Ltd, a developer of stem cell technologies and regenerative medicines, has announced that the Advanced Stem Cell Training Network (ASCTN), a European research...
Press Releases
DefiniGEN licenses CRISPR-Cas9 gene editing technology
DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to...
Clinical Trials
Pharm-Olam is proud to have contributed to the execution and completion of Cablivi ivotal Phase III study
Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for oncology, infectious diseases and vaccines, and rare and orphan diseases, extends its congratulations...
Press Releases
BioBeat unveils 2018’s 50 Movers and Shakers
A new report released unveils 50 female leaders in healthcare business in the UK. Produced by BioBeat, 50 Movers and Shakers in BioBusiness 2018...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read